Cost-Effectiveness of Peginterferon plus Ribavirin in a real-world population of patients with chronic Hepatitis C and associated comorbidities.
In: 39th Annual Meeting of the European Association for the Study of the Liver (EASL), April 14-18 2004
Berlin, Germany (2004)
Buchaufsatz / Kapitel / Fach: Wirtschaftswissenschaften, Rechtswissenschaften
Dieser Eintrag ist freigegeben.
